Publications
Conference
Vermant M, Goos T, Gogaert S, et al., 2023, Current Definitions of Progressive Pulmonary Fibrosis Might Be Inaccurate: Data From a Cohort of Patients With Rheumatoid Arthritis Associated Interstitial Lung Disease, International Conference of the American-Thoracic-Society (ATS), AMER THORACIC SOC, ISSN:1073-449X
Geldof J, Truyens M, Sabino J, et al., 2023, Impact of immunomodulating treatment modalities, active smoking and (repeated) COVID19 vaccination on S-antibody seroconversion in IMID patients. Results of the BELCOMID study: BELgian Cohort study of COVID-19 in Immune Mediated Inflammatory Diseases (IMID), OXFORD UNIV PRESS, Pages:720-722, ISSN:1873-9946
Balsa A, Wassenberg S, Tournadre A, et al., 2022, EFFECT OF FILGOTINIB (FIL) ON BODY WEIGHT (BW) AND BODY MASS INDEX (BMI) AND EFFECT OF BASELINE BMI ON THE EFFICACY AND SAFETY OF FIL IN RHEUMATOID ARTHRITIS (RA), BMJ PUBLISHING GROUP, Pages:516-517, ISSN:0003-4967
Bertrand D, Deprez A, Doumen M, et al., 2022, ON-FLARE RETREATMENT WITH RITUXIMAB IN RHEUMATOID ARTHRITIS: PATIENTS' AND RHEUMATOLOGISTS' PERCEPTIONS, EULAR European Congress of Rheumatology (EULAR), BMJ PUBLISHING GROUP, Pages:1802-1803, ISSN:0003-4967
Bertrand D, Deprez A, Doumen M, et al., 2022, PATIENTS' AND RHEUMATOLOGISTS' PERCEPTIONS REGARDING TAPERING OF RITUXIMAB, BMJ PUBLISHING GROUP, Pages:1803-1803, ISSN:0003-4967